6 TECH OUTLOOKJUNE - 2021EditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe world of pharma has changed dramatically over the last year. The pandemic has certainly prompted pharma organizations to adapt many of their approaches, including drug development. And as drug development trends are changing, it is becoming imperative for organizations to rethink their manufacturing processes.Especially, the trend of personalized medicine will inevitably prompt many of the pharma organizations to partner with CMOs that can offer flexible manufacturing capabilities--able to process small batch sizes and handle several formats of medicine on the same line. By partnering with CMOs that offer modular manufacturing functionalities, pharma organizations will be able to scale up or down based on their requirements. More importantly, with manufacturing out of the way, pharma organizations will be able to refocus their resources on the critical drug development processes, which is the need of the hour. When all things are considered, there is no doubt that the CMO space is on the fast track of evolution. Therefore, to keep up with the changes in the marketplace, pharma organizations must partner with the best CMOs to ramp up their functionalities. In this edition of Pharma Tech Outlook, we bring to you the story of some of the most successful CMOs that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership articles from subject-matter experts and exclusive insights from CXOs in the pharmaceutical space. We hope this edition will provide you with the right assistance in choosing the best CMOs according to your requirements.Let us know your thoughts!The Future of Drug Manufacturing is All About ModularityCopyright © 2021 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JUNE - 7 - 2021, Vol 07 - Issue 04 (ISSN 2644-2787) Published by ValleyMedia Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comsales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:John GothamTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >